Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Compound Bendazol and Hydrochlorothiazide Capsules

Approval Number

国药准字H43021786

Company湖南德康制药股份有限公司

Registration Date

August 16, 2024

Drug Information

Generic Name

复方地巴唑氢氯噻嗪胶囊

Brand Name

安多欣

Dosage Form

胶囊剂

Strength

复方

Drug Type

化学药品

Registration Date

August 16, 2024

Company Information

Applicant Company

Company Name湖南德康制药股份有限公司

Company Address

长沙市高新区金洲大道17号

Manufacturing Company

Company Name湖南德康制药股份有限公司

Company Address

湖南省长沙市高新区金洲大道17号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

复方地巴唑氢氯噻嗪胶囊 - NMPA 批准文号 | MedPath